Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	COSMIC	Related_Results
	TTLL10(15.5%)	exon8,c.745del,p.V249fs	0.155	0.167	35|6	6|0	0.09524	57|6	1	1116222	1116223	CG	C	slippage,distinguished	TTLL10	NM_001130045.2	8	c.745del	p.Val249fs	frameshift_variant					
	MTOR(1.3%)	exon48,c.6730G>A,p.D2244N	0.013	0.015	308|4	73|0	0.00881	450|4	1	11182116	11182116	C	T	PASS	MTOR	NM_004958.4	48	c.6730G>A	p.Asp2244Asn	missense_variant					
	MTOR(1.4%)	exon48,c.6692C>T,p.S2231L	0.014	0.015	407|6	87|0	0.00992	599|6	1	11182154	11182154	G	A	haplotype	MTOR	NM_004958.4	48	c.6692C>T	p.Ser2231Leu	missense_variant				COSV63877777	
	SPEN(57.1%)	exon14,c.10723C>T,p.L3575=	0.571	0.56	9|10	3|3	0.47619	11|10	1	16265231	16265231	C	T	germline,normal_artifact	SPEN	NM_015001.3	14	c.10723C>T	p.Leu3575=	synonymous_variant					
-	ARID1A(1.1%)	exon16,c.4000C>T,p.Q1334*	0.011	0.011	485|6	106|0	0.01105	895|10	1	27100204	27100204	C	T	PASS	ARID1A	NM_006015.6	16	c.4000C>T	p.Gln1334*	stop_gained					
	MUTYH(44.0%)	exon12,c.930G>C,p.Q310H	0.44	0.6	19|11	1|2	0.35484	20|11	1	45797505	45797505	C	G	germline,normal_artifact,Germline	MUTYH	NM_001048174.2	12	c.930G>C	p.Gln310His	missense_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Familial_multiple_polyposis_syndrome|Carcinoma_of_colon|Familial_adenomatous_polyposis_2		
1	NRAS(0.2%)	exon4,c.437C>T,p.A146V	0.002055	0.001235	2325|4	1740|2	0.00159	20750|33	1	115252203	115252203	G	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				COSV65746912	
1	NRAS(17.4%)	exon3,c.182A>T,p.Q61L	0.174	0.0009274	1616|327	1250|0	0.16078	10998|2107	1	115256529	115256529	T	A	clustered_events	NRAS	NM_002524.5	3	c.182A>T	p.Gln61Leu	missense_variant	Uncertain_significance		Melanoma|Neoplasm_of_the_large_intestine|Glioblastoma|Chronic_lymphatic_leukemia|Hepatocellular_carcinoma|Non-small_cell_lung_carcinoma|Malignant_neoplasm_of_body_of_uterus|Thyroid_tumor|Adrenal_cortex_carcinoma|Neoplasia_of_the_nasopharynx|Ovarian_serous_cystadenocarcinoma|Malignant_melanoma_of_skin|Papillary_renal_cell_carcinoma_type_1|Gastric_adenocarcinoma|Neoplasm_of_brain|Multiple_myeloma|Acute_myeloid_leukemia|RASopathy|Lung_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder		
1	NRAS(0.2%)	exon3,c.175G>A,p.A59T	0.00238	0.001708	1854|4	1180|1	0.00048	12462|6	1	115256536	115256536	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		not_provided|Noonan_syndrome_6		
1	NRAS(0.3%)	exon2,c.34G>A,p.G12S	0.002716	0.00067	2992|8	1854|0	0.00216	24498|53	1	115258748	115258748	C	T	clustered_events	NRAS	NM_002524.5	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Noonan_syndrome_and_Noonan-related_syndrome|Melanoma|RASopathy|Juvenile_myelomonocytic_leukemia|Noonan_syndrome|Myelodysplastic_syndrome|Multiple_myeloma|Malignant_melanoma_of_skin|not_provided|Non-small_cell_lung_carcinoma|Gastric_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Neoplasm_of_the_large_intestine|Acute_myeloid_leukemia		
	LCE1F(5.3%)	exon2,c.87C>T,p.C29=	0.053	0.052	103|6	19|0	0.03774	153|6	1	152748934	152748934	C	T	contamination,suspected_bg	LCE1F	NM_178354.3	2	c.87C>T	p.Cys29=	synonymous_variant				COSV57669775	
	SPTA1(93.3%)	exon49,c.6794T>C,p.I2265T	0.933	0.75	0|22	0|2	1.00000	0|27	1	158584091	158584091	A	G	germline,normal_artifact,Germline	SPTA1	NM_003126.4	49	c.6794T>C	p.Ile2265Thr	missense_variant	Benign		not_provided|Pyropoikilocytosis,_hereditary|not_specified|Hereditary_spherocytosis_type_3|Elliptocytosis_2		
	SDHC(0.7%)	exon5,c.277C>A,p.P93T	0.007391	0.001652	1301|9	689|0	0.00454	8547|39	1	161326502	161326502	C	A	suspected_bg,low_allele_frac	SDHC	NM_003001.5	5	c.277C>A	p.Pro93Thr	missense_variant					
	PIK3C2B(3.4%)	exon4,c.896C>T,p.A299V	0.034	0.061	123|4	17|0	0.02339	167|4	1	204438035	204438035	G	A	contamination,distinguished	PIK3C2B	NM_002646.4	4	c.896C>T	p.Ala299Val	missense_variant				COSV65804359	
	FH(2.1%)	exon5,c.585G>A,p.M195I	0.021	0.01	401|9	109|0	0.02086	704|15	1	241672056	241672056	C	T	PASS	FH	NM_000143.4	5	c.585G>A	p.Met195Ile	missense_variant					
	TAF1B(1.1%)	exon3,c.187A>T,p.K63*	0.011	0.004158	1265|21	737|7	0.09195	5491|556	2	9989571	9989571	A	T	background	TAF1B	NM_005680.3	3	c.187A>T	p.Lys63*	stop_gained					
	MYCN(3.4%)	exon2,c.134del,p.P45fs	0.034	0.018	553|26	125|3	0.02669	1313|36	2	16082313	16082314	AC	A	suspected_bg	MYCN	NM_005378.6	2	c.134del	p.Pro45fs	frameshift_variant	Pathogenic		not_provided		
	ALK(0.9%)	exon23,c.3599C>T,p.A1200V	0.008563	0.002844	1550|14	763|2	0.00313	6371|20	2	29443618	29443618	G	A	PASS	ALK	NM_004304.5	23	c.3599C>T	p.Ala1200Val	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome|not_provided|Neuroblastoma,_susceptibility_to,_3		
	ALK(93.8%)	exon1,c.27C>G,p.L9=	0.938	0.75	0|16	0|2	1.00000	0|21	2	30143499	30143499	G	C	germline,normal_artifact,Germline	ALK	NM_004304.5	1	c.27C>G	p.Leu9=	synonymous_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Neuroblastoma,_susceptibility_to,_3		
	EPCAM(0.3%)	exon3,c.330C>T,p.C110=	0.002764	0.001386	3385|9	3095|4	0.00140	53531|75	2	47601092	47601092	C	T	low_allele_frac	EPCAM	NM_002354.3	3	c.330C>T	p.Cys110=	synonymous_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		
-	MSH2(2.7%)	exon2,c.212-5_212-4del	0.027	0.021	868|39	234|7	0.01790	3072|56	2	47635523	47635525	CTT	C	clustered_events,multiallelic,normal_artifact	MSH2	NM_000251.3	2	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		not_specified		
-	MSH2(14.1%)	exon2,c.212-4del	0.141	0.164	868|178	234|62	0.13465	3072|478	2	47635523	47635525	CTT	CT	clustered_events,multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	2	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Lynch_syndrome_1		
-	MSH2(8.2%)	exon2,c.212-4dup	0.082	0.095	868|117	234|34	0.14190	3072|508	2	47635523	47635525	CTT	CTTT	clustered_events,multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	2	c.212-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	MSH2(0.8%)	exon2,c.212-5_212-4dup	0.007749	0.018	868|7	234|5	0.01317	3072|41	2	47635523	47635525	CTT	CTTTT	clustered_events,multiallelic,normal_artifact,low_allele_frac	MSH2	NM_000251.3	2	c.212-5_212-4dup		splice_region_variant&intron_variant					
-	MSH2(1.6%)	exon2,c.212-4T>A	0.016	0.013	1298|23	380|5	0.01667	4425|75	2	47635536	47635536	T	A	clustered_events,contamination,haplotype,normal_artifact,background	MSH2	NM_000251.3	2	c.212-4T>A		splice_region_variant&intron_variant	Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms		
-	MSH6(7.4%)	exon5,c.3261del,p.F1088fs	0.074	0.055	1559|141	758|56	0.05586	9853|583	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Mismatch_repair_cancer_syndrome_3|Lynch-like_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Carcinoma_of_colon|Stomach_cancer|not_provided|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome|Endometrial_carcinoma|Lynch_syndrome_5		
	RANBP2(2.4%)	exon20,c.3479G>A,p.S1160N	0.024	0.024	164|4	42|0	0.01732	227|4	2	109380474	109380474	G	A	PASS	RANBP2	NM_006267.5	20	c.3479G>A	p.Ser1160Asn	missense_variant					
	LRP1B(5.5%)	exon78,c.11908A>G,p.R3970G	0.055	0.074	123|5	30|1	0.02924	166|5	2	141093392	141093392	T	C	normal_artifact,distinguished	LRP1B	NM_018557.3	78	c.11908A>G	p.Arg3970Gly	missense_variant				COSV67236075	
	LRP1B(12.6%)	exon37,c.5976C>A,p.S1992=	0.126	0.011	363|50	113|1	0.11156	661|83	2	141473589	141473589	G	T	PASS	LRP1B	NM_018557.3	37	c.5976C>A	p.Ser1992=	synonymous_variant					
	LRP1B(10.7%)	exon33,c.5443C>T,p.R1815W	0.107	0.035	85|8	30|0	0.08929	102|10	2	141533724	141533724	G	A	PASS	LRP1B	NM_018557.3	33	c.5443C>T	p.Arg1815Trp	missense_variant				COSV67221323	
	LRP1B(1.2%)	exon30,c.4992C>T,p.Y1664=	0.012	0.013	560|7	191|2	0.01329	1188|16	2	141598609	141598609	G	A	normal_artifact	LRP1B	NM_018557.3	30	c.4992C>T	p.Tyr1664=	synonymous_variant					
	LRP1B(2.0%)	exon11,c.1772A>G,p.E591G	0.02	0.018	202|4	72|0	0.01238	319|4	2	141806572	141806572	T	C	haplotype	LRP1B	NM_018557.3	11	c.1772A>G	p.Glu591Gly	missense_variant					
	LRP1B(1.5%)	exon6,c.625G>A,p.A209T	0.015	0.013	474|6	185|1	0.00844	940|8	2	141986977	141986977	C	T	normal_artifact	LRP1B	NM_018557.3	6	c.625G>A	p.Ala209Thr	missense_variant				COSV105329701	
	ERBB4(3.2%)	exon21,c.2518G>A,p.V840I	0.032	0.021	167|4	52|0	0.03051	286|9	2	212295795	212295795	C	T	contamination	ERBB4	NM_005235.3	21	c.2518G>A	p.Val840Ile	missense_variant	Uncertain_significance		Amyotrophic_lateral_sclerosis		
2	BARD1(3.0%)	exon3,c.216-1G>T	0.03	0.173	188|5	22|7	0.11485	316|41	2	215657170	215657170	C	A	base_qual,clustered_events,normal_artifact,strand_bias,weak_evidence,background	BARD1	NM_000465.4	3	c.216-1G>T		splice_acceptor_variant&intron_variant	Pathogenic		Familial_cancer_of_breast		
	UGT1A1(3.2%)	exon0,c.-55_-54insATAT	0.032	0.026	295|59	153|29	0.05592	7107|421	2	234668879	234668881	CAT	CATATAT	clustered_events,germline,multiallelic,normal_artifact,chemotherapy_site	UGT1A1	NM_000463.3	0	c.-55_-54insATAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|drug_response	Pathogenic(3)|Benign(1)	not_provided|Irinotecan_response		
2	FANCD2(8.5%)	exon6,c.378-5del	0.085	0.046	559|66	154|8	0.08450	1181|109	3	10076842	10076843	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	6	c.378-5del		splice_region_variant&intron_variant					
2	FANCD2(5.7%)	exon6,c.378-5dup	0.057	0.039	559|49	154|4	0.05746	1181|72	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	6	c.378-5dup		splice_region_variant&intron_variant					
	TGFBR2(9.2%)	exon4,c.458del,p.K153fs	0.092	0.145	616|70	166|28	0.09620	1381|147	3	30691871	30691873	GAA	GA	multiallelic,normal_artifact,suspected_bg	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|Benign(3)|Likely_benign(1)	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|not_specified|Loeys-Dietz_syndrome		
	MLH1(0.9%)	exon19,c.2188C>T,p.P730S	0.009185	0.003795	1303|13	609|1	0.00568	5429|31	3	37092061	37092061	C	T	PASS	MLH1	NM_000249.4	19	c.2188C>T	p.Pro730Ser	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
	CTNNB1(1.3%)	exon4,c.377C>T,p.A126V	0.013	0.005501	628|9	203|0	0.01164	1274|15	3	41266580	41266580	C	T	PASS	CTNNB1	NM_001904.4	4	c.377C>T	p.Ala126Val	missense_variant					
	ANO10(6.0%)	exon2,c.132del,p.D45fs	0.06	0.046	1278|95	695|35	0.05452	6521|376	3	43647212	43647213	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided		
	ANO10(1.6%)	exon2,c.132dup,p.D45fs	0.016	0.021	1278|33	695|19	0.02846	6521|191	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Autosomal_recessive_cerebellar_ataxia|Autosomal_recessive_spinocerebellar_ataxia_10|Abnormal_central_motor_function|not_provided		
	FOXP1(2.0%)	exon11,c.737G>A,p.G246D	0.02	0.018	365|6	74|0	0.01751	561|10	3	71090611	71090611	C	T	PASS	FOXP1	NM_032682.6	11	c.737G>A	p.Gly246Asp	missense_variant					
	EPHA3(2.0%)	exon7,c.1465G>A,p.A489T	0.02	0.009383	354|6	129|0	0.00902	659|6	3	89448501	89448501	G	A	PASS	EPHA3	NM_005233.6	7	c.1465G>A	p.Ala489Thr	missense_variant					
	GATA2(7.7%)	exon3,c.709G>A,p.G237S	0.077	0.075	63|5	16|0	0.05319	89|5	3	128204732	128204732	C	T	orientation	GATA2	NM_032638.5	3	c.709G>A	p.Gly237Ser	missense_variant	Uncertain_significance		Monocytopenia_with_susceptibility_to_infections|Deafness-lymphedema-leukemia_syndrome		
	GATA2(83.3%)	exon3,c.490G>A,p.A164T	0.833	0.5	0|4	1|1	1.00000	0|5	3	128204951	128204951	C	T	germline,normal_artifact	GATA2	NM_032638.5	3	c.490G>A	p.Ala164Thr	missense_variant	Benign		Monocytopenia_with_susceptibility_to_infections|Deafness-lymphedema-leukemia_syndrome|not_specified|not_provided		
	PIK3CB(1.0%)	exon6,c.679G>A,p.A227T	0.01	0.019	760|8	258|3	0.00761	2086|16	3	138456671	138456671	C	T	normal_artifact	PIK3CB	NM_006219.3	6	c.679G>A	p.Ala227Thr	missense_variant					
	ATR(6.8%)	exon10,c.2320del,p.I774fs	0.068	0.058	2041|178	1508|100	0.05844	15403|956	3	142274739	142274741	ATT	AT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		not_provided|Endometrial_neoplasm		
	ATR(1.7%)	exon10,c.2320dup,p.I774fs	0.017	0.03	2041|66	1508|64	0.05259	15403|855	3	142274739	142274741	ATT	ATTT	multiallelic,normal_artifact,slippage,background	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided|Seckel_syndrome_1		
1	PIK3CA(0.4%)	exon10,c.1624G>A,p.E542K	0.003759	0.0009106	2032|6	1415|0	0.00477	15011|72	3	178936082	178936082	G	A	clustered_events,weak_evidence,background	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		Cowden_syndrome|CLAPO_syndrome|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|Prostate_adenocarcinoma|Neoplasm_of_uterine_cervix|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Lip_and_oral_cavity_carcinoma|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Esophageal_carcinoma|Breast_neoplasm|Neoplasm_of_brain|CLOVES_syndrome|not_provided|Neoplasm_of_ovary|Hepatocellular_carcinoma|Small_cell_lung_carcinoma|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|Abnormality_of_cardiovascular_system_morphology|Transitional_cell_carcinoma_of_the_bladder		
	MUC4(91.0%)	exon2,c.11691_11738del,p.S3898_A3913del	0.91	0.639	6|78	2|4	*	0|0	3	195506712	195506760	AGCTGAGGAAGTGTCGGTGACAGGAAGAGGGGTGGCGTGACGTGTGGAT	A	clustered_events,germline,normal_artifact	MUC4	NM_018406.7	2	c.11691_11738del	p.Ser3898_Ala3913del	disruptive_inframe_deletion	Pathogenic		Hepatocellular_carcinoma		
	MUC4(24.5%)	exon2,c.11468_11563del,p.T3823_T3854del	0.245	0.33	136|38	5|1	0.23077	10|3	3	195506887	195506983	ATGGTGTCACCTGTGGATACTGAGGAAGGGATGGTGACAGGAAGAGGGGTGGCGTGACCTGTGGATGCTGAGGAAGCGTCGGTGACAGGAAGAGGGG	A	clustered_events,germline,normal_artifact	MUC4	NM_018406.7	2	c.11468_11563del	p.Thr3823_Thr3854del	disruptive_inframe_deletion	Pathogenic		Hepatocellular_carcinoma|Lung_cancer		
	MUC4(3.0%)	exon2,c.9893_10000delinsCTGTCACCGACA,p.L3298_P3334>PVTDT	0.03	0.078	225|5	12|0	0.02857	408|12	3	195508451	195508558	GGCTGGTGACATGAAGAGGGGTGGCGTGACCTGTGGATGCTGAGGAAGCGTCGGTGACAAGAAGAGGAGTGGCGTGACCTGTGGATACTGAGGAAGTCTCGGTGACAA	TGTCGGTGACAG	clustered_events,contamination,haplotype,weak_evidence	MUC4	NM_018406.7	2	c.9893_10000delinsCTGTCACCGACA	p.Leu3298_Pro3334delinsProValThrAspThr	missense_variant&disruptive_inframe_deletion	Pathogenic		Hepatocellular_carcinoma|Lung_cancer		
	MUC4(26.0%)	exon2,c.9914_9961del,p.V3305_S3320del	0.26	0.308	181|64	8|3	*	0|0	3	195508489	195508537	GCTGAGGAAGCGTCGGTGACAAGAAGAGGAGTGGCGTGACCTGTGGATA	G	clustered_events,germline,normal_artifact	MUC4	NM_018406.7	2	c.9914_9961del	p.Val3305_Ser3320del	disruptive_inframe_deletion	Pathogenic		Hepatocellular_carcinoma|Small_cell_lung_carcinoma|Lung_cancer		
	MUC4(17.2%)	exon2,c.3365_3460del,p.P1122_L1153del	0.172	0.377	117|16	9|2	0.13333	13|2	3	195514990	195515086	TGAAGAGGGGTGGTGTGACCTGTGGATACTGAGGAAGTGTCGGTGACAGGAAGAGAGGTGGCGTGACCTGTGGATGCTGAGGAAGTGTCGGTGACAG	T	clustered_events,normal_artifact	MUC4	NM_018406.7	2	c.3365_3460del	p.Pro1122_Leu1153del	disruptive_inframe_deletion	Pathogenic		Lung_cancer		
	SLIT2(1.5%)	exon4,c.326G>A,p.R109H	0.015	0.006841	607|8	187|0	0.00667	1341|9	4	20270435	20270435	G	A	PASS	SLIT2	NM_004787.4	4	c.326G>A	p.Arg109His	missense_variant&splice_region_variant					
	KIT(0.8%)	exon5,c.831C>T,p.I277=	0.00765	0.003824	1028|8	322|0	0.00826	2881|24	4	55569964	55569964	C	T	low_allele_frac	KIT	NM_000222.3	5	c.831C>T	p.Ile277=	synonymous_variant				COSV104602165	
	KDR(1.1%)	exon19,c.2714G>A,p.C905Y	0.011	0.00586	860|9	213|0	0.00877	1695|15	4	55962410	55962410	C	T	PASS	KDR	NM_002253.3	19	c.2714G>A	p.Cys905Tyr	missense_variant				COSV99817207	
	KDR(18.2%)	exon13,c.1916_1917delinsTG,p.D639V	0.182	0.002422	941|216	490|0	0.18336	3220|723	4	55970880	55970881	GT	CA	PASS	KDR	NM_002253.3	13	c.1916_1917delinsTG	p.Asp639Val	missense_variant					
	TET2(6.6%)	exon10,c.4239G>A,p.E1413=	0.066	0.061	57|4	18|0	0.06061	62|4	4	106193777	106193777	G	A	PASS	TET2	NM_001127208.3	10	c.4239G>A	p.Glu1413=	synonymous_variant					
	TET2(2.4%)	exon11,c.4643_4645del,p.Q1548del	0.024	0.011	296|8	88|0	0.02241	567|13	4	106196299	106196302	CCAG	C	contamination,haplotype,slippage,distinguished	TET2	NM_001127208.3	11	c.4643_4645del	p.Gln1548del	disruptive_inframe_deletion					
	INPP4B(1.3%)	exon24,c.2409A>G,p.K803=	0.013	0.006307	599|7	192|0	0.01077	1194|13	4	143007375	143007375	T	C	background	INPP4B	NM_001101669.3	24	c.2409A>G	p.Lys803=	synonymous_variant					
-	FBXW7(24.1%)	exon4,c.585-6_585-5del	0.241	0.095	20|7	8|0	0.15385	44|8	4	153268227	153268229	CAA	C	contamination,germline,multiallelic	FBXW7	NM_033632.3	4	c.585-6_585-5del		splice_region_variant&intron_variant					
-	FBXW7(13.4%)	exon4,c.585-4G>T	0.134	0.078	20|4	8|0	0.22807	44|13	4	153268227	153268227	C	A	contamination,germline,multiallelic,background	FBXW7	NM_033632.3	4	c.585-4G>T		splice_region_variant&intron_variant					
	SDHA(5.2%)	exon15,c.1932G>A,p.V644=	0.052	0.053	142|11	20|1	0.08019	195|17	5	256472	256472	G	A	clustered_events,contamination,background	SDHA	NM_004168.4	15	c.1932G>A	p.Val644=	synonymous_variant	Benign		Mitochondrial_complex_II_deficiency,_nuclear_type_1|Paragangliomas_5|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_pheochromocytoma-paraganglioma|Leigh_syndrome		
	MSH3(35.0%)	exon1,c.235A>G,p.I79V	0.35	0.333	12|7	3|1	0.30233	30|13	5	79950781	79950781	A	G	contamination,germline,normal_artifact,Germline	MSH3	NM_002439.5	1	c.235A>G	p.Ile79Val	missense_variant&splice_region_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|Constitutional_megaloblastic_anemia_with_severe_neurologic_disease|not_provided		
	MSH3(1.4%)	exon7,c.1148del,p.K383fs	0.014	0.011	1777|39	1138|16	0.01580	11334|182	5	79970914	79970915	CA	C	contamination,multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic/Likely_pathogenic		Familial_adenomatous_polyposis_4|Hereditary_cancer-predisposing_syndrome|not_provided|Endometrial_carcinoma		
	MSH3(1.5%)	exon7,c.1148dup,p.N385fs	0.015	0.019	1777|40	1138|22	0.01768	11334|204	5	79970914	79970915	CA	CAA	contamination,multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided|Hereditary_cancer-predisposing_syndrome		
-	APC(20.4%)	exon5,c.423-4del	0.204	0.155	339|104	114|24	0.16994	845|173	5	112111309	112111310	TA	T	multiallelic,normal_artifact,distinguished	APC	NM_000038.6	5	c.423-4del		splice_region_variant&intron_variant	Benign		not_specified|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|Hepatocellular_carcinoma|Colorectal_cancer|Stomach_cancer|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Desmoid_disease,_hereditary|not_provided		
-	APC(7.3%)	exon5,c.423-4dup	0.073	0.101	339|42	114|18	0.12797	845|124	5	112111309	112111310	TA	TAA	multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	5	c.423-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		not_specified|Familial_adenomatous_polyposis_1|Hepatocellular_carcinoma|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Stomach_cancer|Desmoid_disease,_hereditary|Colorectal_cancer|Hereditary_cancer-predisposing_syndrome		
	APC(1.1%)	exon16,c.3740C>T,p.A1247V	0.011	0.004648	1148|13	528|2	0.00704	3524|25	5	112175031	112175031	C	T	PASS	APC	NM_000038.6	16	c.3740C>T	p.Ala1247Val	missense_variant					
-	APC(16.1%)	exon16,c.4666dup,p.T1556fs	0.161	0.002918	550|102	357|0	0.14573	1571|268	5	112175951	112175951	G	GA	PASS	APC	NM_000038.6	16	c.4666dup	p.Thr1556fs	frameshift_variant	Pathogenic		Familial_adenomatous_polyposis_1|Hereditary_cancer-predisposing_syndrome|Carcinoma_of_colon|not_provided		
	RAD50(6.4%)	exon13,c.2165del,p.K722fs	0.064	0.053	3328|270	2442|170	0.04875	53676|2751	5	131931451	131931452	TA	T	clustered_events,multiallelic,normal_artifact,slippage,background	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome		
	RAD50(1.2%)	exon13,c.2165dup,p.E723fs	0.012	0.019	3328|80	2442|73	0.02882	53676|1593	5	131931451	131931452	TA	TAA	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided|Breast_and/or_ovarian_cancer|Nijmegen_breakage_syndrome-like_disorder		
	CTNNA1(1.5%)	exon9,c.1259C>T,p.A420V	0.015	0.014	382|5	93|0	0.01072	646|7	5	138223294	138223294	C	T	PASS	CTNNA1	NM_001903.5	9	c.1259C>T	p.Ala420Val	missense_variant				COSV105136035	
	CSF1R(45.5%)	exon3,c.294C>T,p.H98=	0.455	0.193	14|17	3|0	0.54839	14|17	5	149460343	149460343	G	A	germline,Germline	CSF1R	NM_005211.4	3	c.294C>T	p.His98=	synonymous_variant	Benign		not_provided|not_specified|Hereditary_diffuse_leukoencephalopathy_with_spheroids		
	FGFR4(92.3%)	exon6,c.702C>T,p.R234=	0.923	0.652	0|19	0|1	1.00000	0|19	5	176518784	176518784	C	T	germline,normal_artifact,Germline	FGFR4	NM_213647.3	6	c.702C>T	p.Arg234=	synonymous_variant				COSV52807660	
	NSD1(51.5%)	exon23,c.6829T>C,p.L2277=	0.515	0.8	21|20	0|3	0.46667	24|21	5	176721198	176721198	T	C	germline,normal_artifact,Germline	NSD1	NM_022455.5	23	c.6829T>C	p.Leu2277=	synonymous_variant	Benign		not_specified|Inborn_genetic_diseases|Sotos_syndrome		
	FLT4(54.5%)	exon19,c.2670C>G,p.H890Q	0.545	0.333	6|8	1|0	0.62500	6|10	5	180046344	180046344	G	C	germline	FLT4	NM_182925.5	19	c.2670C>G	p.His890Gln	missense_variant	Benign		not_specified|Congenital_heart_defects,_multiple_types,_7|not_provided|Hereditary_lymphedema_type_I		
	FLT4(3.6%)	exon2,c.89del,p.P30fs	0.036	0.039	356|16	40|1	0.04043	451|19	5	180058747	180058748	CG	C	suspected_bg	FLT4	NM_182925.5	2	c.89del	p.Pro30fs	frameshift_variant	Pathogenic		Congenital_heart_defects,_multiple_types,_7|not_provided		
	CYP21A2(36.7%)	exon1,c.29_31del,p.L10del	0.367	0.333	22|12	2|0	0.26087	34|12	6	32006214	32006217	CCTG	C	contamination,germline,slippage,Germline	CYP21A2	NM_000500.9	1	c.29_31del	p.Leu10del	disruptive_inframe_deletion	Benign		not_specified|not_provided		
	VEGFA(34.8%)	exon1,c.328C>T,p.R110*	0.348	0.035	44|25	27|0	0.40123	97|65	6	43738771	43738771	C	T	PASS	VEGFA	NM_001025366.3	1	c.328C>T	p.Arg110*	stop_gained					
	ROS1(0.5%)	exon31,c.5217C>T,p.S1739=	0.00464	0.0005746	3185|15	4119|2	0.00148	64126|95	6	117658366	117658366	G	A	low_allele_frac	ROS1	NM_002944.3	31	c.5217C>T	p.Ser1739=	synonymous_variant					
	ROS1(0.8%)	exon18,c.2803C>T,p.P935S	0.008112	0.004401	1344|11	555|1	0.00536	4827|26	6	117687248	117687248	G	A	background	ROS1	NM_002944.3	18	c.2803C>T	p.Pro935Ser	missense_variant					
	ARID1B(6.5%)	exon18,c.4733C>T,p.S1578F	0.065	0.097	51|4	8|0	0.05714	66|4	6	157522092	157522092	C	T	orientation	ARID1B	NM_001374828.1	18	c.4733C>T	p.Ser1578Phe	missense_variant					
-	ARID1B(1.3%)	exon18,c.4957C>T,p.Q1653*	0.013	0.027	412|6	87|1	0.00882	674|6	6	157522316	157522316	C	T	normal_artifact,background	ARID1B	NM_001374828.1	18	c.4957C>T	p.Gln1653*	stop_gained	Pathogenic		not_provided		
	CARD11(2.2%)	exon4,c.225G>A,p.R75=	0.022	0.03	281|5	45|0	0.01241	398|5	7	2985586	2985586	C	T	haplotype	CARD11	NM_032415.7	4	c.225G>A	p.Arg75=	synonymous_variant					
	PMS2(0.3%)	exon11,c.1572A>G,p.P524=	0.003492	0.0005957	3286|14	1890|3	0.00395	33798|134	7	6026824	6026824	T	C	low_allele_frac	PMS2	NM_000535.7	11	c.1572A>G	p.Pro524=	synonymous_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms		
2	PMS2(2.3%)	exon7,c.706-7_706-4del	0.023	0.035	289|34	45|12	0.02984	2016|62	7	6037057	6037061	GAAAA	G	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-7_706-4del		splice_region_variant&intron_variant	Benign		not_specified		
2	PMS2(8.2%)	exon7,c.706-6_706-4del	0.082	0.045	289|117	45|17	0.12119	2016|278	7	6037057	6037061	GAAAA	GA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-6_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_specified|Malignant_tumor_of_breast|not_provided		
2	PMS2(4.4%)	exon7,c.706-5_706-4dup	0.044	0.045	289|66	45|15	0.10638	2016|240	7	6037057	6037061	GAAAA	GAAAAAA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-5_706-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Breast_and/or_ovarian_cancer|not_specified		
1	EGFR(0.3%)	exon18,c.2125G>A,p.E709K	0.002686	0.002056	1744|4	591|0	0.00273	7310|20	7	55241677	55241677	G	A	clustered_events,weak_evidence	EGFR	NM_005228.5	18	c.2125G>A	p.Glu709Lys	missense_variant	drug_response		Tyrosine_kinase_inhibitor_response		
1	EGFR(0.4%)	exon18,c.2156G>A,p.G719D	0.004081	0.002587	1307|4	433|0	0.00137	5089|7	7	55241708	55241708	G	A	clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	18	c.2156G>A	p.Gly719Asp	missense_variant	Likely_pathogenic		Glioblastoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Lung_adenocarcinoma		
1	EGFR(0.1%)	exon19,c.2235_2249del,p.E746_A750del	0.00092	0.0008725	3096|1	1502|0	0.00006	17354|1	7	55242464	55242479	AGGAATTAAGAGAAGC	A	contamination,weak_evidence	EGFR	NM_005228.5	19	c.2235_2249del	p.Glu746_Ala750del	disruptive_inframe_deletion	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	Lung_cancer|EGFR-related_lung_cancer|Lung_adenocarcinoma|Tyrosine_kinase_inhibitor_response		
1	EGFR(0.3%)	exon20,c.2386G>A,p.G796S	0.002877	0.007707	1505|4	319|2	0.00107	3720|4	7	55249088	55249088	G	A	clustered_events,normal_artifact,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2386G>A	p.Gly796Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|Uncertain_significance(1)	not_provided|EGFR-related_lung_cancer		
1	EGFR(0.6%)	exon20,c.2387G>A,p.G796D	0.005608	0.003833	1508|7	319|0	0.00284	3860|11	7	55249089	55249089	G	A	clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant	Uncertain_significance		EGFR-related_lung_cancer		
	MAGI2(45.4%)	exon22,c.4329C>G,p.P1443=	0.454	0.666	5|5	0|1	0.44444	5|4	7	77648671	77648671	G	C	contamination,germline,normal_artifact,Germline	MAGI2	NM_012301.4	22	c.4329C>G	p.Pro1443=	synonymous_variant	Benign		Nephrotic_syndrome_15|not_specified|not_provided		
	PIK3CG(37.4%)	exon2,c.89C>G,p.A30G	0.374	0.667	12|6	1|3	0.28571	15|6	7	106508095	106508095	C	G	germline,normal_artifact	PIK3CG	NM_002649.3	2	c.89C>G	p.Ala30Gly	missense_variant					
	PIK3CG(23.4%)	exon7,c.2569A>G,p.T857A	0.234	0.499	55|15	3|2	0.20000	68|17	7	106522592	106522592	A	G	germline,normal_artifact,Germline	PIK3CG	NM_002649.3	7	c.2569A>G	p.Thr857Ala	missense_variant				COSV63247183	
	PIK3CG(1.7%)	exon10,c.2950C>T,p.P984S	0.017	0.008866	714|11	135|0	0.01048	1322|14	7	106526657	106526657	C	T	suspected_bg	PIK3CG	NM_002649.3	10	c.2950C>T	p.Pro984Ser	missense_variant					
1	MET(0.1%)	exon14,c.2888-1G>A	0.001121	0.0003524	4178|4	3335|0	0.00119	54396|65	7	116411902	116411902	G	A	orientation,weak_evidence	MET	NM_000245.4	14	c.2888-1G>A		splice_acceptor_variant&intron_variant					
1	MET(0.3%)	exon14,c.3028+1G>A	0.002709	0.0009739	3991|10	3673|3	0.00216	61047|132	7	116412044	116412044	G	A	clustered_events,normal_artifact,orientation	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided		
	SMO(68.2%)	exon2,c.536C>T,p.T179M	0.682	0.5	6|15	0|0	0.76190	5|16	7	128843429	128843429	C	T	germline	SMO	NM_005631.5	2	c.536C>T	p.Thr179Met	missense_variant&splice_region_variant	Uncertain_significance		Microcephaly		
	BRAF(0.2%)	exon15,c.1796C>T,p.T599I	0.001806	0.0005548	2721|4	2310|0	0.00104	29829|31	7	140453139	140453139	G	A	clustered_events,orientation,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Melanoma|Neoplasm|not_provided|RASopathy|Noonan_syndrome|Cardiofaciocutaneous_syndrome_1		
	KEL(2.1%)	exon14,c.1573C>T,p.Q525*	0.021	0.011	457|10	101|0	0.02142	868|19	7	142640889	142640889	G	A	orientation	KEL	NM_000420.3	14	c.1573C>T	p.Gln525*	stop_gained					
	KEL(3.3%)	exon10,c.1153C>T,p.R385C	0.033	0.063	126|4	18|0	0.02222	176|4	7	142649646	142649646	G	A	contamination,orientation	KEL	NM_000420.3	10	c.1153C>T	p.Arg385Cys	missense_variant				COSV100786835	
-	KMT2C(5.7%)	exon38,c.8390del,p.K2797fs	0.057	0.044	2504|174	1718|105	0.05633	23939|1429	7	151874147	151874149	CTT	CT	multiallelic,normal_artifact,slippage,background	KMT2C	NM_170606.3	38	c.8390del	p.Lys2797fs	frameshift_variant	Pathogenic		Small_cell_lung_carcinoma		
-	KMT2C(0.5%)	exon38,c.8389_8390del,p.K2797fs	0.004917	0.003538	2504|14	1718|6	0.00346	23939|83	7	151874147	151874149	CTT	C	multiallelic,normal_artifact,slippage,low_allele_frac	KMT2C	NM_170606.3	38	c.8389_8390del	p.Lys2797fs	frameshift_variant	Pathogenic		Small_cell_lung_carcinoma		
-	KMT2C(2.5%)	exon38,c.8390dup,p.E2798fs	0.025	0.034	2504|97	1718|78	0.03844	23939|957	7	151874147	151874149	CTT	CTTT	multiallelic,normal_artifact,slippage,background	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided		
	KMT2C(3.0%)	exon14,c.2418C>G,p.S806=	0.03	0.007882	931|29	141|0	0.05712	1469|89	7	151945101	151945101	G	C	clustered_events,contamination,background	KMT2C	NM_170606.3	14	c.2418C>G	p.Ser806=	synonymous_variant	Benign		not_provided		
	KMT2C(8.4%)	exon7,c.925C>T,p.P309S	0.084	0.108	1402|122	228|24	0.07931	2496|215	7	151970877	151970877	G	A	clustered_events,normal_artifact,background	KMT2C	NM_170606.3	7	c.925C>T	p.Pro309Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	Lung_cancer|Tip-toe_gait		
	RP1L1(4.7%)	exon4,c.4019_4020delinsGG,p.E1340G	0.047	0.066	1605|27	268|4	0.16747	5379|1082	8	10467588	10467589	TT	CC	clustered_events,strand_bias,suspected_bg	RP1L1	NM_178857.6	4	c.4019_4020delinsGG	p.Glu1340Gly	missense_variant					
	PRKDC(3.6%)	exon77,c.10811del,p.N3604fs	0.036	0.016	247|6	62|0	0.01754	392|7	8	48701554	48701555	GT	G	contamination,slippage,suspected_bg	PRKDC	NM_006904.7	77	c.10811del	p.Asn3604fs	frameshift_variant					
	PRKDC(1.3%)	exon75,c.10521A>T,p.K3507N	0.013	0.015	426|6	81|0	0.00836	712|6	8	48706997	48706997	T	A	PASS	PRKDC	NM_006904.7	75	c.10521A>T	p.Lys3507Asn	missense_variant					
	PRKDC(1.5%)	exon40,c.5155G>A,p.A1719T	0.015	0.016	386|6	80|0	0.01029	577|6	8	48792129	48792129	C	T	PASS	PRKDC	NM_006904.7	40	c.5155G>A	p.Ala1719Thr	missense_variant					
	PTCH1(1.1%)	exon20,c.3412C>T,p.L1138=	0.011	0.012	889|8	208|2	0.00863	2067|18	9	98215797	98215797	G	A	normal_artifact	PTCH1	NM_000264.5	20	c.3412C>T	p.Leu1138=	synonymous_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|Gorlin_syndrome		
	PTCH1(69.9%)	exon1,c.37C>G,p.R13G	0.699	0.332	2|6	5|2	0.50000	7|7	9	98270607	98270607	G	C	germline,normal_artifact	PTCH1	NM_000264.5	1	c.37C>G	p.Arg13Gly	missense_variant	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(5)|Benign(2)|Likely_benign(2)	Basal_cell_carcinoma,_susceptibility_to,_1|Gorlin_syndrome|Holoprosencephaly_7|Hereditary_cancer-predisposing_syndrome|not_provided		
	ABL1(1.5%)	exon3,c.409G>A,p.A137T	0.015	0.007839	542|7	147|0	0.00890	1002|9	9	133730343	133730343	G	A	PASS	ABL1	NM_005157.6	3	c.409G>A	p.Ala137Thr	missense_variant					
	ABL1(5.3%)	exon11,c.1826_1828del,p.K609del	0.053	0.014	489|25	74|0	0.03022	1091|34	9	133759489	133759492	CAAG	C	contamination,slippage,suspected_bg	ABL1	NM_005157.6	11	c.1826_1828del	p.Lys609del	disruptive_inframe_deletion	Pathogenic		Lung_cancer		
-	TSC1(14.2%)	exon21,c.2626-5_2626-4del	0.142	0.067	52|31	10|2	0.09224	433|44	9	135773000	135773002	GAA	G	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-5_2626-4del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|Lymphangiomyomatosis|Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_1|not_specified|not_provided		
-	TSC1(14.0%)	exon21,c.2626-4del	0.14	0.175	52|33	10|6	0.12348	433|61	9	135773000	135773002	GAA	GA	multiallelic,normal_artifact,distinguished	TSC1	NM_000368.5	21	c.2626-4del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Tuberous_sclerosis_syndrome|Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_1		
-	TSC1(17.9%)	exon21,c.2626-4dup	0.179	0.19	52|34	10|4	0.16891	433|88	9	135773000	135773002	GAA	GAAA	multiallelic,normal_artifact,distinguished	TSC1	NM_000368.5	21	c.2626-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Lymphangiomyomatosis|Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_1|not_specified|not_provided		
-	TSC1(12.4%)	exon21,c.2626-5_2626-4dup	0.124	0.19	52|22	10|3	0.10352	433|50	9	135773000	135773002	GAA	GAAAA	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-5_2626-4dup		splice_region_variant&intron_variant	Benign		not_specified|Hereditary_cancer-predisposing_syndrome|Lymphangiomyomatosis|Tuberous_sclerosis_1|Isolated_focal_cortical_dysplasia_type_II|not_provided		
-	TSC1(6.7%)	exon21,c.2626-7_2626-4dup	0.067	0.132	52|8	10|3	0.06681	433|31	9	135773000	135773002	GAA	GAAAAAA	multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-7_2626-4dup		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		
	TSC1(0.9%)	exon15,c.1847C>T,p.A616V	0.008964	0.024	633|6	140|3	0.00942	1157|11	9	135781118	135781118	G	A	normal_artifact	TSC1	NM_000368.5	15	c.1847C>T	p.Ala616Val	missense_variant					
	TSC1(17.3%)	exon15,c.1768C>T,p.P590S	0.173	0.006668	527|111	167|0	0.15154	1131|202	9	135781197	135781197	G	A	PASS	TSC1	NM_000368.5	15	c.1768C>T	p.Pro590Ser	missense_variant	Uncertain_significance		Tuberous_sclerosis_1		
	NOTCH1(11.2%)	exon9,c.1508G>A,p.G503D	0.112	0.167	30|4	4|0	0.08696	42|4	9	139411771	139411771	C	T	PASS	NOTCH1	NM_017617.5	9	c.1508G>A	p.Gly503Asp	missense_variant				COSV53034348	
	KAT6B(0.4%)	exon16,c.3288_3305del,p.E1097_E1102del	0.004443	0.001528	1297|5	733|0	0.00136	5873|8	10	76781896	76781914	GGAAGAAGAGGAAGAAGAA	G	low_allele_frac	KAT6B	NM_012330.4	16	c.3288_3305del	p.Glu1097_Glu1102del	disruptive_inframe_deletion					
-	PTEN(0.3%)	exon1,c.79+1G>A	0.003058	0.002488	3216|9	1448|2	0.00309	23229|72	10	89624306	89624306	G	A	clustered_events,low_allele_frac	PTEN	NM_000314.8	1	c.79+1G>A		splice_donor_variant&intron_variant	Likely_pathogenic		PTEN_hamartoma_tumor_syndrome		
-	PTEN(4.2%)	exon8,c.802-4_802-3del	0.042	0.035	301|32	96|10	0.04746	1686|84	10	89720633	89720635	CTT	C	clustered_events,germline,multiallelic,normal_artifact,background	PTEN	NM_000314.8	8	c.802-4_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided		
-	PTEN(12.9%)	exon8,c.802-3del	0.129	0.13	301|91	96|27	0.16823	1686|341	10	89720633	89720635	CTT	CT	clustered_events,germline,multiallelic,normal_artifact,suspected_bg	PTEN	NM_000314.8	8	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|PTEN_hamartoma_tumor_syndrome		
-	PTEN(6.8%)	exon8,c.802-4_802-3dup	0.068	0.124	301|57	96|24	0.11216	1686|213	10	89720633	89720635	CTT	CTTTT	clustered_events,germline,multiallelic,normal_artifact,background	PTEN	NM_000314.8	8	c.802-4_802-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Macrocephaly-autism_syndrome|Familial_meningioma|Malignant_tumor_of_prostate|Glioma_susceptibility_2|Cowden_syndrome_1|not_specified|Breast_and/or_ovarian_cancer		
-	PTEN(4.3%)	exon8,c.802-2A>T	0.043	0.067	776|42	248|35	0.13306	3323|510	10	89720649	89720649	A	T	base_qual,clustered_events,normal_artifact,background	PTEN	NM_000314.8	8	c.802-2A>T		splice_acceptor_variant&intron_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided|PTEN_hamartoma_tumor_syndrome|Cowden_syndrome_1		
	IFITM3(3.8%)	exon1,c.208C>A,p.P70T	0.038	0.041	300|13	33|1	0.04471	406|19	11	320606	320606	G	T	contamination,background	IFITM3	NM_021034.3	1	c.208C>A	p.Pro70Thr	missense_variant				COSV67706711	
	KRTAP5-1(36.6%)	exon1,c.330_359del,p.S111_G120del	0.366	0.558	12|5	0|0	0.00000	1|0	11	1606120	1606150	ACCACAGCCACCCTTGGATCCCCCACAAGAG	A	contamination,germline	KRTAP5-1	NM_001005922.1	1	c.330_359del	p.Ser111_Gly120del	disruptive_inframe_deletion					
	WT1(4.7%)	exon9,c.1388G>A,p.R463Q	0.047	0.046	111|4	22|0	0.02857	136|4	11	32413577	32413577	C	T	chemotherapy_site	WT1	NM_024426.6	9	c.1388G>A	p.Arg463Gln	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Likely_pathogenic(1)|Uncertain_significance(2)	Wilms_tumor_1|11p_partial_monosomy_syndrome|Aniridia_1|Nephrotic_syndrome,_type_4|Drash_syndrome|Frasier_syndrome|Mesothelioma,_malignant|Meacham_syndrome|Focal_segmental_glomerulosclerosis		
	WT1(84.1%)	exon1,c.345C>T,p.P115=	0.841	0.5	0|4	0|0	1.00000	0|4	11	32456562	32456562	G	A	germline,chemotherapy_site	WT1	NM_024426.6	1	c.345C>T	p.Pro115=	synonymous_variant	Benign		Wilms_tumor_1|Drash_syndrome|Frasier_syndrome|Nephrotic_syndrome,_type_4|11p_partial_monosomy_syndrome|not_specified|not_provided|Meacham_syndrome		
	ESRRA(14.9%)	exon7,c.1124_1134delinsAGCTGCCA,p.R375_A378>QLP	0.149	0.12	107|16	23|3	0.10063	143|16	11	64083290	64083300	GGCGGCGGGCG	AGCTGCCA	clustered_events,haplotype,normal_artifact	ESRRA	NM_004451.5	7	c.1124_1134delinsAGCTGCCA	p.Arg375_Ala378delinsGlnLeuPro	missense_variant&conservative_inframe_deletion					
	ESRRA(17.8%)	exon7,c.1152_1154delinsACC,p.L385P	0.178	0.125	83|24	23|3	0.20139	115|29	11	64083318	64083320	GCT	ACC	clustered_events,haplotype,normal_artifact	ESRRA	NM_004451.5	7	c.1152_1154delinsACC	p.Leu385Pro	missense_variant					
	ESRRA(17.4%)	exon7,c.1162_1165delinsTTCT,p.L388_R389>FC	0.174	0.13	87|23	22|3	0.22388	104|30	11	64083328	64083331	CTCC	TTCT	clustered_events,haplotype,normal_artifact	ESRRA	NM_004451.5	7	c.1162_1165delinsTTCT	p.Leu388_Arg389delinsPheCys	missense_variant					
	MEN1(2.3%)	exon10,c.1735G>A,p.A579T	0.023	0.021	312|7	53|0	0.01426	484|7	11	64571919	64571919	C	T	PASS	MEN1	NM_000244.3	10	c.1735G>A	p.Ala579Thr	missense_variant	Uncertain_significance		Multiple_endocrine_neoplasia,_type_1		
	GSTP1(1.1%)	exon6,c.387T>C,p.P129=	0.011	0.005496	750|7	216|0	0.00884	1682|15	11	67353625	67353625	T	C	background,chemotherapy_site	GSTP1	NM_000852.4	6	c.387T>C	p.Pro129=	synonymous_variant					
	CCND1(3.3%)	exon5,c.724G>T,p.D242Y	0.033	0.061	125|4	17|0	0.03488	166|6	11	69465886	69465886	G	T	PASS	CCND1	NM_053056.3	5	c.724G>T	p.Asp242Tyr	missense_variant&splice_region_variant					
	USP35(54.2%)	exon10,c.2029A>G,p.I677V	0.542	0.483	9|15	2|3	0.54286	16|19	11	77920930	77920930	A	G	germline,normal_artifact,Germline	USP35	NM_020798.4	10	c.2029A>G	p.Ile677Val	missense_variant				COSV71572644	
-	ATM(2.2%)	exon6,c.497-6_497-4del	0.022	0.022	192|4	64|1	0.01004	493|5	11	108114661	108114664	ATTT	A	multiallelic,normal_artifact	ATM	NM_000051.4	6	c.497-6_497-4del		splice_region_variant&intron_variant					
-	ATM(16.6%)	exon6,c.497-4dup	0.166	0.099	192|54	64|11	0.17696	493|106	11	108114661	108114664	ATTT	ATTTT	multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	6	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Ataxia-telangiectasia_syndrome		
-	ATM(4.3%)	exon10,c.1236-4_1236-3del	0.043	0.086	136|16	42|7	0.07772	356|30	11	108121410	108121412	CTT	C	germline,multiallelic,normal_artifact	ATM	NM_000051.4	10	c.1236-4_1236-3del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_provided|not_specified|Breast_and/or_ovarian_cancer		
-	ATM(14.5%)	exon10,c.1236-3del	0.145	0.112	136|55	42|10	0.21930	356|100	11	108121410	108121412	CTT	CT	germline,multiallelic,normal_artifact,background	ATM	NM_000051.4	10	c.1236-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Ataxia-telangiectasia_syndrome		
-	ATM(30.9%)	exon10,c.1236-3dup	0.309	0.139	136|98	42|11	0.33333	356|178	11	108121410	108121412	CTT	CTTT	germline,multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	10	c.1236-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	ATM(6.2%)	exon10,c.1236-4_1236-3dup	0.062	0.067	136|23	42|5	0.13171	356|54	11	108121410	108121412	CTT	CTTTT	germline,multiallelic,normal_artifact	ATM	NM_000051.4	10	c.1236-4_1236-3dup		splice_acceptor_variant&intron_variant	Benign		not_specified		
-	ATM(3.9%)	exon10,c.1236-2A>T	0.039	0.049	355|15	85|5	0.07799	733|62	11	108121426	108121426	A	T	contamination,normal_artifact,background	ATM	NM_000051.4	10	c.1236-2A>T		splice_acceptor_variant&intron_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Ataxia-telangiectasia_syndrome		
-	ATM(1.6%)	exon14,c.2165del,p.L722fs	0.016	0.016	360|7	74|0	0.01528	580|9	11	108126978	108126979	CT	C	contamination,haplotype	ATM	NM_000051.4	14	c.2165del	p.Leu722fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Ataxia-telangiectasia_syndrome		
	ATM(1.6%)	exon14,c.2169G>A,p.V723=	0.016	0.016	370|6	75|0	0.01634	602|10	11	108126986	108126986	G	A	haplotype	ATM	NM_000051.4	14	c.2169G>A	p.Val723=	synonymous_variant					
	ATM(1.7%)	exon25,c.3631G>A,p.A1211T	0.017	0.009696	421|7	125|0	0.00937	740|7	11	108153491	108153491	G	A	PASS	ATM	NM_000051.4	25	c.3631G>A	p.Ala1211Thr	missense_variant	Uncertain_significance		Ataxia-telangiectasia_syndrome		
-	ATM(1.2%)	exon27,c.3994-3C>T	0.012	0.009511	509|6	131|0	0.01258	942|12	11	108158324	108158324	C	T	orientation	ATM	NM_000051.4	27	c.3994-3C>T		splice_region_variant&intron_variant					
-	ATM(1.5%)	exon35,c.5188C>T,p.R1730*	0.015	0.012	497|7	98|0	0.00871	911|8	11	108172385	108172385	C	T	PASS	ATM	NM_000051.4	35	c.5188C>T	p.Arg1730*	stop_gained	Pathogenic/Likely_pathogenic		Stomach_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Ataxia-telangiectasia_syndrome		
	CD3G(5.4%)	exon3,c.213del,p.K71fs	0.054	0.027	1195|77	441|14	0.05549	3813|224	11	118220582	118220583	TA	T	normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|Likely_pathogenic(1)|Uncertain_significance(1)	Combined_immunodeficiency_due_to_CD3gamma_deficiency|Severe_combined_immunodeficiency_disease		
	KMT2A(1.8%)	exon3,c.2318del,p.P773fs	0.018	0.012	1223|57	574|12	0.01700	8151|141	11	118344185	118344186	AC	A	normal_artifact,background	KMT2A	NM_001197104.2	3	c.2318del	p.Pro773fs	frameshift_variant	Pathogenic		Inborn_genetic_diseases|Wiedemann-Steiner_syndrome		
	KMT2A(1.4%)	exon27,c.10012G>A,p.A3338T	0.014	0.007193	519|7	166|0	0.00745	933|7	11	118376619	118376619	G	A	PASS	KMT2A	NM_001197104.2	27	c.10012G>A	p.Ala3338Thr	missense_variant					
	CBL(4.2%)	exon9,c.1380_1382del,p.D460del	0.042	0.053	138|5	18|0	0.04149	231|10	11	119149355	119149358	TATG	T	contamination,slippage,suspected_bg	CBL	NM_005188.4	9	c.1380_1382del	p.Asp460del	disruptive_inframe_deletion	Uncertain_significance		RASopathy|CBL-related_disorder		
	CBL(1.2%)	exon13,c.2111C>T,p.S704F	0.012	0.007649	769|10	177|0	0.00752	1451|11	11	119167702	119167702	C	T	PASS	CBL	NM_005188.4	13	c.2111C>T	p.Ser704Phe	missense_variant	Uncertain_significance		not_provided		
	CHD4(1.9%)	exon30,c.4508G>A,p.R1503H	0.019	0.024	286|6	96|1	0.01268	467|6	12	6691310	6691310	C	T	normal_artifact	CHD4	NM_001273.5	30	c.4508G>A	p.Arg1503His	missense_variant				COSV104622867	
1	KRAS(0.2%)	exon3,c.175G>A,p.A59T	0.001801	0.0007148	2110|6	1799|0	0.00159	20740|33	12	25380283	25380283	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic		
-	ARID2(12.9%)	exon15,c.2749C>T,p.Q917*	0.129	0.003796	840|125	300|0	0.13813	2109|338	12	46244655	46244655	C	T	PASS	ARID2	NM_152641.4	15	c.2749C>T	p.Gln917*	stop_gained					
	KMT2D(12.5%)	exon40,c.10765A>G,p.T3589A	0.125	0.146	30|4	6|0	0.10256	35|4	12	49427723	49427723	T	C	PASS	KMT2D	NM_003482.4	40	c.10765A>G	p.Thr3589Ala	missense_variant					
	KMT2D(2.6%)	exon16,c.4278G>A,p.E1426=	0.026	0.034	185|6	33|0	0.02091	281|6	12	49440532	49440532	C	T	orientation	KMT2D	NM_003482.4	16	c.4278G>A	p.Glu1426=	synonymous_variant					
-	KMT2D(1.4%)	exon11,c.2425del,p.Q809fs	0.014	0.015	2057|59	725|13	0.00972	20368|200	12	49445040	49445041	TG	T	clustered_events,normal_artifact,suspected_bg	KMT2D	NM_003482.4	11	c.2425del	p.Gln809fs	frameshift_variant	Likely_pathogenic		Kabuki_syndrome_1		
-	KMT2D(0.3%)	exon11,c.2317C>T,p.Q773*	0.002817	0.000788	2901|8	1584|1	0.00285	35309|101	12	49445149	49445149	G	A	clustered_events,low_allele_frac	KMT2D	NM_003482.4	11	c.2317C>T	p.Gln773*	stop_gained	Pathogenic		not_provided		
	OR6C76(0.5%)	exon1,c.932A>C,p.K311T	0.005346	0.0008067	2027|10	1551|0	0.00171	21049|36	12	55820969	55820969	A	C	low_allele_frac	OR6C76	NM_001005183.1	1	c.932A>C	p.Lys311Thr	missense_variant				COSV60388962	
	GLI1(6.9%)	exon8,c.805G>A,p.V269M	0.069	0.1	82|4	13|0	0.04211	91|4	12	57860065	57860065	G	A	PASS	GLI1	NM_005269.3	8	c.805G>A	p.Val269Met	missense_variant				COSV104391298	
	GLI1(11.1%)	exon10,c.1304C>T,p.A435V	0.111	0.053	41|4	17|0	0.09259	49|5	12	57862003	57862003	C	T	PASS	GLI1	NM_005269.3	10	c.1304C>T	p.Ala435Val	missense_variant					
	CDK4(1.6%)	exon4,c.404G>A,p.C135Y	0.016	0.024	466|7	99|1	0.00877	791|7	12	58144824	58144824	C	T	normal_artifact	CDK4	NM_000075.4	4	c.404G>A	p.Cys135Tyr	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
	CDK4(0.2%)	exon2,c.70C>T,p.R24C	0.002469	0.001561	3149|7	2382|3	0.00264	29455|78	12	58145431	58145431	G	A	normal_artifact,orientation,weak_evidence,low_allele_frac	CDK4	NM_000075.4	2	c.70C>T	p.Arg24Cys	missense_variant	Pathogenic		Familial_melanoma|Hereditary_cancer-predisposing_syndrome|not_provided|Melanoma,_cutaneous_malignant,_susceptibility_to,_3|Multiple_myeloma|Malignant_melanoma_of_skin|Lung_adenocarcinoma		
	SCYL2(1.1%)	exon17,c.2092A>G,p.S698G	0.011	0.003018	644|6	387|1	0.00731	2174|16	12	100731231	100731231	A	G	PASS	SCYL2	NM_017988.6	17	c.2092A>G	p.Ser698Gly	missense_variant					
	HNF1A(36.9%)	exon7,c.1375C>T,p.L459=	0.369	0.6	14|10	1|3	0.37931	18|11	12	121435342	121435342	C	T	clustered_events,germline,normal_artifact,Germline	HNF1A	NM_000545.8	7	c.1375C>T	p.Leu459=	synonymous_variant	Benign/Likely_benign		not_specified|Maturity_onset_diabetes_mellitus_in_young|not_provided|Maturity-onset_diabetes_of_the_young_type_3|Nonpapillary_renal_cell_carcinoma|Type_II_diabetes_mellitus		
	HNF1A(43.4%)	exon7,c.1460G>A,p.S487N	0.434	0.659	18|13	1|3	0.38889	22|14	12	121435427	121435427	G	A	clustered_events,germline,normal_artifact,orientation,Germline	HNF1A	NM_000545.8	7	c.1460G>A	p.Ser487Asn	missense_variant	Benign		Maturity_onset_diabetes_mellitus_in_young|not_specified|not_provided|Maturity-onset_diabetes_of_the_young_type_3|Nonpapillary_renal_cell_carcinoma|Type_II_diabetes_mellitus		
	ORAI1(91.7%)	exon1,c.138_143del,p.P47_P48del	0.917	0.667	0|13	0|1	1.00000	0|17	12	122064773	122064779	CCCGCCA	C	germline,normal_artifact,Germline	ORAI1	NM_032790.3	1	c.138_143del	p.Pro47_Pro48del	disruptive_inframe_deletion					
	NCOR2(34.0%)	exon16,c.1529_1531dup,p.Q510dup	0.34	0.333	31|15	1|0	0.33663	67|34	12	124887058	124887058	G	GGCT	germline,slippage	NCOR2	NM_006312.6	16	c.1529_1531dup	p.Gln510dup	conservative_inframe_insertion	Benign		not_provided		
	FLT3(1.8%)	exon23,c.2781T>C,p.A927=	0.018	0.019	395|7	63|0	0.01131	612|7	13	28588667	28588667	A	G	PASS	FLT3	NM_004119.3	23	c.2781T>C	p.Ala927=	synonymous_variant					
-	BRCA2(2.5%)	exon10,c.1813del,p.I605fs	0.025	0.02	1296|44	778|16	0.02637	5908|160	13	32907420	32907421	GA	G	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Stomach_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Familial_cancer_of_breast|Fanconi_anemia_complementation_group_D1		
-	BRCA2(1.2%)	exon11,c.5351del,p.N1784fs	0.012	0.006598	1379|17	751|5	0.00821	5554|46	13	32913836	32913837	CA	C	normal_artifact,background	BRCA2	NM_000059.4	11	c.5351del	p.Asn1784fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_2		
-	BRCA2(2.0%)	exon23,c.9097dup,p.T3033fs	0.02	0.027	1048|23	666|19	0.02002	4454|91	13	32954022	32954022	C	CA	contamination,normal_artifact,slippage,background	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Stomach_cancer|Breast_and/or_ovarian_cancer|Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Neoplasm_of_ovary|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_carcinoma|Malignant_tumor_of_breast		
	NBEA(1.3%)	exon22,c.3362del,p.N1121fs	0.013	0.004708	1864|29	1040|5	0.01280	10028|130	13	35733662	35733663	TA	T	contamination,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362del	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		
-	RB1(4.3%)	exon7,c.608-4del	0.043	0.025	1996|113	2057|67	0.03864	30554|1228	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Retinoblastoma		
-	RB1(2.4%)	exon7,c.608-4dup	0.024	0.032	1996|66	2057|78	0.03545	30554|1123	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Retinoblastoma		
	FGF14(1.3%)	exon4,c.537G>A,p.G179=	0.013	0.029	411|5	109|3	0.01140	694|8	13	102379032	102379032	C	T	normal_artifact	FGF14	NM_004115.4	4	c.537G>A	p.Gly179=	synonymous_variant					
	IRS2(39.4%)	exon1,c.3099A>G,p.P1033=	0.394	0.5	20|12	1|2	0.41304	27|19	13	110435302	110435302	T	C	germline,normal_artifact,Germline	IRS2	NM_003749.3	1	c.3099A>G	p.Pro1033=	synonymous_variant	Likely_benign		not_provided		
	ARHGAP5(1.2%)	exon2,c.1438_1441delinsTGAT,p.R480*	0.012	0.001336	1204|11	922|0	0.00404	5171|21	14	32561313	32561316	CGAG	TGAT	haplotype	ARHGAP5	NM_001030055.2	2	c.1438_1441delinsTGAT	p.Arg480*	stop_gained					
	NFKBIA(11.9%)	exon5,c.796C>T,p.Q266*	0.119	0.1	30|4	9|0	0.11111	32|4	14	35871710	35871710	G	A	orientation	NFKBIA	NM_020529.3	5	c.796C>T	p.Gln266*	stop_gained					
	DDHD1(80.0%)	exon1,c.273C>T,p.F91=	0.8	0.8	0|5	0|3	1.00000	0|9	14	53619544	53619544	G	A	clustered_events,germline,normal_artifact,Germline	DDHD1	NM_001160148.2	1	c.273C>T	p.Phe91=	synonymous_variant	Benign		not_specified|Hereditary_spastic_paraplegia_28		
	HSP90AA1(1.3%)	exon7,c.1439A>G,p.K480R	0.013	0.005239	486|6	194|0	0.00627	1584|10	14	102550810	102550810	T	C	haplotype	HSP90AA1	NM_001017963.3	7	c.1439A>G	p.Lys480Arg	missense_variant					
	GOLGA6L4(72.6%)	exon6,c.1279G>A,p.D427N	0.726	0.5	7|25	1|1	0.78947	8|30	15	84909385	84909385	G	A	germline,haplotype,normal_artifact,Germline	GOLGA6L4	NM_001267536.3	6	c.1279G>A	p.Asp427Asn	missense_variant				COSV65606843	
	NTRK3(97.2%)	exon7,c.573C>T,p.N191=	0.972	0.667	0|47	0|1	1.00000	0|56	15	88680684	88680684	G	A	germline,normal_artifact,Germline	NTRK3	NM_001012338.3	7	c.573C>T	p.Asn191=	synonymous_variant	Benign		not_provided		
	BLM(2.9%)	exon7,c.1544del,p.N515fs	0.029	0.027	3590|145	3907|130	0.02759	90508|2568	15	91304138	91304139	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided		
	BLM(1.4%)	exon7,c.1544dup,p.N515fs	0.014	0.02	3590|84	3907|94	0.02820	90508|2626	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,slippage,background	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Bloom_syndrome		
	CHD2(3.8%)	exon7,c.679G>A,p.A227T	0.038	0.031	162|7	37|0	0.03004	226|7	15	93482935	93482935	G	A	distinguished	CHD2	NM_001271.4	7	c.679G>A	p.Ala227Thr	missense_variant					
	CHD2(5.9%)	exon29,c.3734del,p.K1245fs	0.059	0.056	493|36	141|9	0.05380	1020|58	15	93540315	93540316	GA	G	normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(4)|Likely_pathogenic(1)|Uncertain_significance(1)	Developmental_and_epileptic_encephalopathy_94|not_specified|not_provided|History_of_neurodevelopmental_disorder		
	CHD2(4.2%)	exon33,c.4173del,p.K1391fs	0.042	0.021	151|6	43|0	0.03614	240|9	15	93545433	93545434	GA	G	contamination,slippage,weak_evidence,distinguished	CHD2	NM_001271.4	33	c.4173del	p.Lys1391fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|Uncertain_significance(2)	not_specified|Developmental_and_epileptic_encephalopathy_94|Intellectual_disability		
	AXIN1(54.0%)	exon2,c.762T>C,p.D254=	0.54	0.25	38|41	2|0	0.50575	43|44	16	396264	396264	A	G	germline,Germline	AXIN1	NM_003502.4	2	c.762T>C	p.Asp254=	synonymous_variant	Benign		not_specified		
	PALB2(1.0%)	exon4,c.886del,p.M296*	0.01	0.009244	2019|20	1929|18	0.00961	28031|272	16	23646980	23646981	AT	A	normal_artifact,suspected_bg	PALB2	NM_024675.4	4	c.886del	p.Met296*	frameshift_variant&stop_gained	Pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast		
	CTCF(1.1%)	exon6,c.1186A>G,p.R396G	0.011	0.015	620|6	158|1	0.00731	1087|8	16	67654699	67654699	A	G	normal_artifact	CTCF	NM_006565.4	6	c.1186A>G	p.Arg396Gly	missense_variant					
	PLCG2(2.2%)	exon6,c.534C>T,p.S178=	0.022	0.027	267|5	48|0	0.01622	364|6	16	81902873	81902873	C	T	orientation	PLCG2	NM_002661.5	6	c.534C>T	p.Ser178=	synonymous_variant					
	PLCG2(92.2%)	exon16,c.1497C>T,p.A499=	0.922	0.652	0|12	0|1	1.00000	0|12	16	81941319	81941319	C	T	germline,normal_artifact,Germline	PLCG2	NM_002661.5	16	c.1497C>T	p.Ala499=	synonymous_variant	Benign		not_specified|not_provided|Autoinflammation-PLCG2-associated_antibody_deficiency-immune_dysregulation|Familial_cold_autoinflammatory_syndrome_3		
	FANCA(36.0%)	exon40,c.3982A>G,p.T1328A	0.36	0.204	26|17	3|0	0.40426	28|19	16	89805914	89805914	T	C	germline,Germline	FANCA	NM_000135.4	40	c.3982A>G	p.Thr1328Ala	missense_variant	Benign		not_specified|not_provided|Fanconi_anemia|Fanconi_anemia_complementation_group_A		
	FANCA(0.8%)	exon38,c.3803T>C,p.L1268P	0.007837	0.005847	800|6	217|0	0.00306	1954|6	16	89807237	89807237	A	G	low_allele_frac	FANCA	NM_000135.4	38	c.3803T>C	p.Leu1268Pro	missense_variant					
	FANCA(4.9%)	exon11,c.924C>T,p.G308=	0.049	0.037	159|7	28|0	0.04255	225|10	16	89862396	89862396	G	A	contamination	FANCA	NM_000135.4	11	c.924C>T	p.Gly308=	synonymous_variant	Likely_benign		Fanconi_anemia		
2	FANCA(2.5%)	exon9,c.793-5G>A	0.025	0.048	196|4	22|0	0.01423	277|4	16	89866051	89866051	C	T	haplotype,orientation	FANCA	NM_000135.4	9	c.793-5G>A		splice_region_variant&intron_variant					
	TP53(19.0%)	exon7,c.742C>T,p.R248W	0.19	0.004535	636|150	286|0	0.17945	1701|372	17	7577539	7577539	G	A	PASS	TP53	NM_000546.6	7	c.742C>T	p.Arg248Trp	missense_variant	Pathogenic		Gallbladder_cancer|Malignant_neoplasm_of_body_of_uterus|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Uterine_carcinosarcoma|Prostate_adenocarcinoma|Cognitive_impairment|Acute_myeloid_leukemia|Pectus_excavatum|Abnormality_of_the_tongue|Pancytopenia|Webbed_neck|Short_stature|Congenital_fibrosarcoma|Neoplasm|Lip_and_oral_cavity_carcinoma|Neoplasm_of_brain|Glioblastoma|Pancreatic_adenocarcinoma|Breast_neoplasm|Stomach_cancer|Esophageal_carcinoma|Breast_and/or_ovarian_cancer|Malignant_lymphoma,_large_B-cell,_diffuse|Hereditary_cancer-predisposing_syndrome|not_provided|Chronic_lymphatic_leukemia|Myelodysplastic_syndrome|Hepatocellular_carcinoma|Multiple_myeloma|Neoplasm_of_ovary|Malignant_melanoma_of_skin|Li-Fraumeni_syndrome_1|Squamous_cell_lung_carcinoma|Small_cell_lung_carcinoma|Choroid_plexus_carcinoma|Lung_adenocarcinoma|Li-Fraumeni_syndrome|Medulloblastoma|Squamous_cell_carcinoma_of_the_head_and_neck|Squamous_cell_carcinoma_of_the_skin|Brainstem_glioma|Transitional_cell_carcinoma_of_the_bladder		
	LGALS9B(85.7%)	exon1,c.17C>G,p.S6C	0.857	0.667	0|5	0|1	1.00000	0|5	17	20370767	20370767	G	C	clustered_events,germline,normal_artifact,Germline	LGALS9B	NM_001042685.3	1	c.17C>G	p.Ser6Cys	missense_variant	Benign		not_specified		
-	NF1(2.1%)	exon2,c.61-4del	0.021	0.034	578|14	141|5	0.01718	1201|21	17	29482988	29482989	CT	C	contamination,multiallelic,normal_artifact,slippage,weak_evidence,background	NF1	NM_000267.3	2	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Cardiovascular_phenotype|not_specified|not_provided|Neurofibromatosis-Noonan_syndrome|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis,_familial_spinal|Neurofibromatosis,_type_1		
-	NF1(1.5%)	exon2,c.61-4dup	0.015	0.021	578|8	141|4	0.01879	1201|23	17	29482988	29482989	CT	CTT	contamination,multiallelic,normal_artifact,slippage,weak_evidence,suspected_bg	NF1	NM_000267.3	2	c.61-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|Neurofibromatosis,_type_1|Hereditary_cancer-predisposing_syndrome		
-	NF1(1.7%)	exon18,c.2033del,p.P678fs	0.017	0.007952	1279|27	238|2	0.01455	4469|66	17	29553477	29553478	AC	A	contamination,background	NF1	NM_000267.3	18	c.2033del	p.Pro678fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_provided		
	NF1(1.4%)	exon39,c.5796G>A,p.L1932=	0.014	0.008469	489|7	148|0	0.01302	834|11	17	29661902	29661902	G	A	PASS	NF1	NM_000267.3	39	c.5796G>A	p.Leu1932=	synonymous_variant					
1	ERBB2(15.9%)	exon17,c.2033G>A,p.R678Q	0.159	0.012	348|67	90|0	0.15944	659|125	17	37879658	37879658	G	A	PASS	ERBB2	NM_004448.4	17	c.2033G>A	p.Arg678Gln	missense_variant	Likely_pathogenic		Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Breast_neoplasm|Transitional_cell_carcinoma_of_the_bladder		
	TOP2A(1.6%)	exon19,c.2234C>T,p.A745V	0.016	0.015	343|5	74|0	0.00904	548|5	17	38560453	38560453	G	A	PASS	TOP2A	NM_001067.4	19	c.2234C>T	p.Ala745Val	missense_variant					
	KRTAP4-7(2.7%)	exon1,c.132T>C,p.C44=	0.027	0.013	597|12	106|1	0.03806	1011|40	17	39240590	39240590	T	C	orientation,background	KRTAP4-7	NM_033061.3	1	c.132T>C	p.Cys44=	synonymous_variant				COSV66951132	
	STAT3(38.9%)	exon20,c.1854C>T,p.G618=	0.389	0.5	16|8	0|0	0.55263	17|21	17	40475056	40475056	G	A	germline	STAT3	NM_139276.3	20	c.1854C>T	p.Gly618=	synonymous_variant	Benign		not_specified|Hyper-IgE_recurrent_infection_syndrome_1,_autosomal_dominant|STAT3_gain_of_function|not_provided		
-	BRCA1(1.1%)	exon10,c.2572C>T,p.Q858*	0.011	0.003949	760|6	293|0	0.00369	1619|6	17	41244976	41244976	G	A	haplotype,orientation,weak_evidence	BRCA1	NM_007294.4	10	c.2572C>T	p.Gln858*	stop_gained	Pathogenic		not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_neoplasm		
-	BRCA1(0.5%)	exon3,c.134+1G>A	0.005417	0.003198	1744|9	763|1	0.00283	9165|26	17	41267742	41267742	C	T	orientation,low_allele_frac	BRCA1	NM_007294.4	3	c.134+1G>A		splice_donor_variant&intron_variant	Pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome		
-	RNF43(5.5%)	exon9,c.1976del,p.G659fs	0.055	0.023	230|15	50|0	0.04045	427|18	17	56435160	56435161	AC	A	distinguished	RNF43	NM_017763.6	9	c.1976del	p.Gly659fs	frameshift_variant	Likely_pathogenic		not_provided		
	RNF43(68.9%)	exon9,c.1252C>A,p.L418M	0.689	0.667	4|13	0|1	0.72222	5|13	17	56435885	56435885	G	T	germline,normal_artifact,Germline	RNF43	NM_017763.6	9	c.1252C>A	p.Leu418Met	missense_variant	Benign		not_provided|not_specified		
	PRKAR1A(2.7%)	exon7,c.674G>A,p.G225D	0.027	0.036	152|4	30|0	0.01843	213|4	17	66522019	66522019	G	A	PASS	PRKAR1A	NM_002734.5	7	c.674G>A	p.Gly225Asp	missense_variant					
	RPTOR(42.2%)	exon18,c.2010T>C,p.L670=	0.422	0.332	94|74	10|3	0.42995	118|89	17	78865546	78865546	T	C	germline,normal_artifact,Germline	RPTOR	NM_020761.3	18	c.2010T>C	p.Leu670=	synonymous_variant				COSV60807799	
	RPTOR(38.3%)	exon26,c.3117C>T,p.A1039=	0.383	0.334	43|31	7|3	0.40260	46|31	17	78919558	78919558	C	T	germline,normal_artifact,Germline	RPTOR	NM_020761.3	26	c.3117C>T	p.Ala1039=	synonymous_variant				COSV60809154	
	TXNDC2(2.4%)	exon2,c.895_984del,p.L299_D328del	0.024	0.015	594|23	79|0	0.01299	76|1	18	9887329	9887419	TCCAAGTCCCCAGAAGAAGCCATCCAGCCCAAGGAGGGTGACCTCCCCAAGTCCCTAGAGGAAGCCATCCAGCCCAAGGAGGGTGACATCC	T	clustered_events,contamination	TXNDC2	NM_001098529.2	2	c.895_984del	p.Leu299_Asp328del	conservative_inframe_deletion					
	BCL2(7.5%)	exon2,c.384A>C,p.G128=	0.075	0.084	60|5	13|0	0.06410	73|5	18	60985516	60985516	T	G	distinguished	BCL2	NM_000633.3	2	c.384A>C	p.Gly128=	synonymous_variant					
	BCL2(23.1%)	exon2,c.279C>T,p.V93=	0.231	0.143	11|4	5|0	0.23529	13|4	18	60985621	60985621	G	A	orientation	BCL2	NM_000633.3	2	c.279C>T	p.Val93=	synonymous_variant					
	MAP2K2(94.7%)	exon6,c.660C>A,p.I220=	0.947	0.667	0|27	0|1	1.00000	0|33	19	4101062	4101062	G	T	germline,normal_artifact,Germline	MAP2K2	NM_030662.4	6	c.660C>A	p.Ile220=	synonymous_variant	Benign		Cardiovascular_phenotype|Cardiofaciocutaneous_syndrome_4|not_specified|not_provided|RASopathy		
	KANK3(1.0%)	exon8,c.2064C>T,p.V688=	0.01	0.018	463|4	72|0	0.00552	721|4	19	8389853	8389853	G	A	haplotype	KANK3	NM_198471.3	8	c.2064C>T	p.Val688=	synonymous_variant					
	NOTCH3(34.8%)	exon3,c.303C>T,p.T101=	0.348	0.426	18|9	3|2	0.35714	18|10	19	15303225	15303225	G	A	germline,normal_artifact,Germline	NOTCH3	NM_000435.3	3	c.303C>T	p.Thr101=	synonymous_variant	Benign		Lateral_meningocele_syndrome|not_provided|not_specified|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1		
	JAK3(3.1%)	exon19,c.2558C>T,p.A853V	0.031	0.038	113|4	29|0	0.03012	161|5	19	17943450	17943450	G	A	orientation	JAK3	NM_000215.4	19	c.2558C>T	p.Ala853Val	missense_variant					
	PIK3R2(90.9%)	exon8,c.937T>C,p.S313P	0.909	0.796	0|11	0|3	1.00000	0|13	19	18273047	18273047	T	C	germline,normal_artifact,Germline	PIK3R2	NM_005027.4	8	c.937T>C	p.Ser313Pro	missense_variant	Benign		not_specified|Megalencephaly-polymicrogyria-polydactyly-hydrocephalus_syndrome_1		
	PIK3R2(83.3%)	exon15,c.1911T>C,p.S637=	0.833	0.5	0|5	0|0	1.00000	0|5	19	18279638	18279638	T	C	germline	PIK3R2	NM_005027.4	15	c.1911T>C	p.Ser637=	synonymous_variant	Benign		not_specified|not_provided|Megalencephaly-polymicrogyria-polydactyly-hydrocephalus_syndrome_1		
	FCGBP(25.2%)	exon29,c.13098A>G,p.P4366=	0.252	0.167	39|12	5|0	0.15942	58|11	19	40367862	40367862	T	C	germline,Germline	FCGBP	NM_003890.2	29	c.13098A>G	p.Pro4366=	synonymous_variant				COSV55426346	
	AXL(88.0%)	exon7,c.796A>G,p.N266D	0.88	0.764	0|9	0|3	1.00000	0|12	19	41743861	41743861	A	G	germline,normal_artifact,Germline	AXL	NM_021913.5	7	c.796A>G	p.Asn266Asp	missense_variant	Benign		not_provided		
	BAX(2.1%)	exon3,c.121del,p.E41fs	0.021	0.025	817|27	257|6	0.01493	2243|34	19	49458970	49458971	TG	T	normal_artifact,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon		
	POLD1(89.2%)	exon4,c.324G>A,p.A108=	0.892	0.5	0|9	0|0	1.00000	0|9	19	50905042	50905042	G	A	germline,Germline	POLD1	NM_002691.4	4	c.324G>A	p.Ala108=	synonymous_variant	Benign		Mandibular_hypoplasia-deafness-progeroid_syndrome|Colorectal_cancer,_susceptibility_to,_10|not_provided|Hereditary_cancer-predisposing_syndrome|not_specified		
	SSTR4(7.5%)	exon1,c.792C>A,p.V264=	0.075	0.107	48|4	9|0	0.04301	89|4	20	23016912	23016912	C	A	clustered_events,chemotherapy_site	SSTR4	NM_001052.4	1	c.792C>A	p.Val264=	synonymous_variant					
	BCL2L1(1.3%)	exon3,c.635G>A,p.R212H	0.013	0.011	496|6	105|0	0.01044	853|9	20	30253819	30253819	C	T	PASS	BCL2L1	NM_138578.3	3	c.635G>A	p.Arg212His	missense_variant					
	ASXL1(55.6%)	exon13,c.1954G>A,p.G652S	0.556	0.5	3|4	3|3	0.50000	4|4	20	31022469	31022469	G	A	germline,normal_artifact	ASXL1	NM_015338.6	13	c.1954G>A	p.Gly652Ser	missense_variant	Benign		not_specified|not_provided|Bohring-Opitz_syndrome		
	SRC(91.7%)	exon12,c.1218G>C,p.A406=	0.917	0.666	0|16	0|1	1.00000	0|15	20	36030939	36030939	G	C	germline,normal_artifact	SRC	NM_198291.3	12	c.1218G>C	p.Ala406=	synonymous_variant				COSV62440282	
	ADNP(2.3%)	exon5,c.3047dup,p.A1017fs	0.023	0.019	2917|84	1592|33	0.02797	24887|716	20	49508203	49508204	CT	CTT	multiallelic,normal_artifact,suspected_bg	ADNP	NM_015339.5	5	c.3047dup	p.Ala1017fs	frameshift_variant	Likely_pathogenic		not_provided		
	ADNP(0.4%)	exon5,c.3037G>A,p.A1013T	0.004349	0.001871	3159|14	1714|2	0.00242	25114|61	20	49508214	49508214	C	T	low_allele_frac	ADNP	NM_015339.5	5	c.3037G>A	p.Ala1013Thr	missense_variant					
	ARFRP1(97.3%)	exon7,c.483A>C,p.R161=	0.973	0.75	0|54	0|2	1.00000	0|58	20	62331989	62331989	T	G	germline,normal_artifact,Germline	ARFRP1	NM_001267547.3	7	c.483A>C	p.Arg161=	synonymous_variant				COSV53926154	
	KRTAP10-6(42.1%)	exon1,c.206C>G,p.P69R	0.421	0.5	13|8	0|0	0.40909	13|9	21	46012160	46012160	G	C	clustered_events,germline,Germline	KRTAP10-6	NM_198688.3	1	c.206C>G	p.Pro69Arg	missense_variant				COSV59950986	
	SLC19A1(96.5%)	exon2,c.80A>G,p.H27R	0.965	0.8	0|39	0|3	1.00000	0|51	21	46957794	46957794	T	C	germline,normal_artifact,Germline	SLC19A1	NM_194255.4	2	c.80A>G	p.His27Arg	missense_variant	drug_response		not_provided|Gastrointestinal_stroma_tumor|methotrexate_response_-_Efficacy		
	CRKL(1.4%)	exon3,c.854T>C,p.L285P	0.014	0.009094	943|13	283|1	0.01527	2451|38	22	21304075	21304075	T	C	normal_artifact	CRKL	NM_005207.4	3	c.854T>C	p.Leu285Pro	missense_variant					
	LZTR1(18.7%)	exon21,c.2500G>A,p.A834T	0.187	0.167	38|9	4|0	0.15000	51|9	22	21351614	21351614	G	A	PASS	LZTR1	NM_006767.4	21	c.2500G>A	p.Ala834Thr	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome|Cardiovascular_phenotype|not_provided		
	SMARCB1(45.0%)	exon7,c.897G>A,p.S299=	0.45	0.339	31|26	6|3	0.46154	35|30	22	24167513	24167513	G	A	germline,haplotype,normal_artifact	SMARCB1	NM_003073.5	7	c.897G>A	p.Ser299=	synonymous_variant	Benign		not_specified|Schwannomatosis_1|Rhabdoid_tumor_predisposition_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_provided		
	NEFH(37.8%)	exon4,c.2009T>A,p.V670E	0.378	0.569	23|7	0|0	0.06647	323|23	22	29885638	29885638	T	A	germline,haplotype	NEFH	NM_021076.4	4	c.2009T>A	p.Val670Glu	missense_variant	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(1)|Benign(2)|Likely_benign(1)	Inborn_genetic_diseases|Amyotrophic_lateral_sclerosis|not_provided		
	CYP2D6(10.7%)	exon7,c.986G>T,p.R329L	0.107	0.027	467|51	114|2	0.10026	700|78	22	42523636	42523636	C	A	normal_artifact,chemotherapy_site	CYP2D6	NM_000106.6	7	c.986G>T	p.Arg329Leu	missense_variant&splice_region_variant				COSV62242939	
	KDM6A(1.3%)	exon10,c.806C>T,p.A269V	0.013	0.015	438|6	84|0	0.01816	973|18	X	44913131	44913131	C	T	PASS	KDM6A	NM_021140.4	10	c.806C>T	p.Ala269Val	missense_variant				COSV65040360	
	MED12(5.9%)	exon43,c.6306_6308del,p.Q2103del	0.059	0.095	104|7	9|0	0.05628	218|13	X	70361097	70361100	ACAG	A	clustered_events,contamination,slippage,suspected_bg	MED12	NM_005120.3	43	c.6306_6308del	p.Gln2103del	disruptive_inframe_deletion	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(1)|Likely_benign(1)	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|FG_syndrome_1		
	STAG2(1.9%)	exon28,c.2907C>T,p.A969=	0.019	0.016	321|6	65|0	0.00968	614|6	X	123215361	123215361	C	T	PASS	STAG2	NM_001042749.2	28	c.2907C>T	p.Ala969=	synonymous_variant					
	BCORL1(4.8%)	exon12,c.4704A>G,p.K1568=	0.048	0.056	113|4	22|0	0.03681	157|6	X	129185842	129185842	A	G	contamination,orientation	BCORL1	NM_021946.5	12	c.4704A>G	p.Lys1568=	synonymous_variant					
